Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130950 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDC34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLIT1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC389895 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR1D2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3GL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC339166 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LONP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UROD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on